Peter G. Colman - Concepedia

Author

Peter G. Colman

Also Known As

Colman, P, Colman, P., Colman, Peter G., ENDIA Study Group*, Elizabeth Vale, Fergus Cameron, Heli Suomalainen, J Buckner, J. Buckner, John Teerlink

391

Publications

21.5K

Citations

H-Index

112

Concepts

All Affiliations

The Royal Melbourne Hospital The University of Melbourne Walter and Eliza Hall Institute of Medical Research St Vincent's Hospital Melbourne The University of Sydney

About

Peter G. Colman is an author at The Royal Melbourne Hospital specializing in medicine, diabetes, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	50	10.6K
2	Public Health	15	17	7.2K
3	Allergy	9	9	694
4	Health Sciences	8	8	590
5	Biostatistics	1	1	40

Peter G. Colman

160

Publications

17.5K

Citations

H-Index

Page 1

	Year	Citations
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial A Keech, R. John Simes, Philip J. Barter, The Lancet Diabetes ManagementCardiovascular DiseaseHealth PolicyLong-term Fenofibrate TherapyDiabetes	2005	3.2K
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Persistent Poststroke Hyperglycemia Is Independently Associated With Infarct Expansion and Worse Clinical Outcome Tracey Baird, Mark Parsons, Thanh G. Phan, Stroke	2003	630
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Charles F. Verge, David Stenger, Ezio Bonifacio, Diabetes	1998	424
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Margo C. Honeyman, Barbara S. Coulson, Natalie L. Stone, Diabetes Humoral ResponseImmunologyPathologyPancreas TransplantationType 1	2000	384
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial John R. Petrie, Nish Chaturvedi, Ian Ford, The Lancet Diabetes & Endocrinology Metabolic SyndromeType 1Diabetes ManagementCardiovascular DiseaseDiabetes	2017	337
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial Kushwin Rajamani, Peter G. Colman, Li Ping Li, The Lancet Diabetes ManagementField StudyInsulin ManagementDiabetesType 2	2009	322
Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele Grant Morahan, Dexing Huang, Susie I. Ymer, Nature Genetics Type 1Allelic VariantGenetic DeterminantDiabetes EpidemiologyAutoimmune Disease	2001	320
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial Chantal Mathieu, Bernard Zinman, Joanna Uddén, Diabetes Care	2016	301

Page 1